Fanle | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Fanle
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Fanle

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 11 USDMF, 5 JDMF, 5 EU WC, 14 KDMF, 8 NDC API, 14 Listed Suppliers, $ API Reference Price

35 API Suppliers
11 USDMF
5 JDMF
5 EU WC
14 KDMF
8 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers, 27 FDA Orange Book, 45 Europe, 9 Canada, 26 Australia, 6 South Africa, 8 Listed Dossiers

121 FDF Dossiers
27 FDA Orange Book
45 Europe
9 Canada
26 Australia
6 South Africa
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 12 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 38 Disintegrants & Superdisintegrants, 32 Direct Compression, 31 Granulation, 29 Thickeners and Stabilizers, 28 Solubilizers, 22 Lubricants & Glidants, 21 Controlled & Modified Release, 17 Topical, 14 Film Formers & Plasticizers, 11 Parenteral, 10 Chewable & Orodispersible Aids, 10 Co-Processed Excipients, 9 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

52 Fillers, Diluents & Binders
43 Coating Systems & Additives
38 Disintegrants & Superdisintegrants
32 Direct Compression
31 Granulation
29 Thickeners and Stabilizers
28 Solubilizers
22 Lubricants & Glidants
21 Controlled & Modified Release
17 Topical
14 Film Formers & Plasticizers
11 Parenteral
10 Chewable & Orodispersible Aids
10 Co-Processed Excipients
9 Emulsifying Agents
7 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
4 Taste Masking
4 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 62 Regulatory FDF Prices

7 US Medicaid Prescriptions
62 Regulatory FDF Prices

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

11 Others

11 Others

$ API Ref.Price (USD/KG) : 685 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Gowling Strathy & Henderson

filter Patent Reset all filters

7 All

01 32086756

02 22173505

03 22176392

filter Product Reset all filters

7 All

01 7Famciclovir

filter Dosage Reset all filters

7 All

01 7Tablet

filter Exp Date Reset all filters

7 All

01 32011-07-03

02 22014-10-04

03 22014-11-11

Product Main Page

01

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Famciclovir

Brand Name : FAMVIR

Patent Number : 2173505

Filing Date : 1994-10-04

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2176392

Filing Date : 1994-11-11

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Famciclovir

Brand Name : FAMVIR

Patent Number : 2173505

Filing Date : 1994-10-04

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2176392

Filing Date : 1994-11-11

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gowling Strathy & Henderson

Famciclovir

Pharmaconex

Not Confirmed

Gowling Strathy & Henderson

Canada

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 500 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!